We are live on
!
Find out more
PM
Prosight Management Portfolio holdings
AUM
$610M
1-Year Est. Return
40.86%
This Fund
S&P 500
This Quarter
Est. Return
+4.78%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$484M
AUM Growth
+$67.4M
(+16%)
Cap. Flow
+$73.1M
Cap. Flow
% of AUM
15.11%
Top 10 Holdings %
Top 10 Hldgs %
57.22%
Holding
53
New
11
Increased
11
Reduced
16
Closed
14
Top Buys
| 1 |
Procept Biorobotics
PRCT
|
+$43.2M |
| 2 |
Janux Therapeutics
JANX
|
+$35.9M |
| 3 |
Nektar Therapeutics
NKTR
|
+$31M |
| 4 |
Veeva Systems
VEEV
|
+$23.9M |
| 5 |
Phreesia
PHR
|
+$20.2M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
+$21.8M |
| 2 |
BridgeBio Pharma
BBIO
|
+$15.4M |
| 3 |
Roivant Sciences
ROIV
|
+$14M |
| 4 |
DexCom
DXCM
|
+$13.1M |
| 5 |
Immunovant
IMVT
|
+$10.1M |
Sector Composition
| 1 | Healthcare | 99.58% |
| 2 | Industrials | 0.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Procept Biorobotics
PRCT
$1.08B
| $43.4M | 8.97% |
1,380,000
+1,303,009
| +1,692% | +$43.2M |
|
|
LKFT
2
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $35.1M | 7.26% |
1,074,112
-75,888
| -7% | -$2.45M |
|
|
3
Janux Therapeutics
JANX
$973M
| $33M | 6.82% |
2,392,523
+1,527,173
| +176% | +$35.9M |
|
4
ADC Therapeutics
ADCT
$158M
| $29.9M | 6.18% |
8,477,338
+1,005,035
| +13% | +$4.08M |
|
5
Kura Oncology
KURA
$1B
| $26.3M | 5.43% |
2,529,600
-228,916
| -8% | -$2.4M |
|
6
MeiraGTx Holdings
MGTX
$1.16B
| $25.5M | 5.27% |
3,209,788
-879,721
| -22% | -$7.31M |
|
|
7
Nektar Therapeutics
NKTR
$2.28B
| $23.4M | 4.85% |
+554,633
| New | +$31M |
|
|
8
Veeva Systems
VEEV
$31.6B
| $20.1M | 4.16% |
+90,133
| New | +$23.9M |
|
9
Icon
ICLR
$13B
| $20M | 4.14% |
110,000
+500
| +0.5% | +$89K |
|
10
Boston Scientific
BSX
$64.6B
| $20M | 4.14% |
210,000
+133,900
| +176% | +$13.1M |
|
|
CON
11
Concentra Group Holdings
CON
$3.93B
| $17.5M | 3.62% |
891,030
+281,030
| +46% | +$5.62M |
|
|
12
Phreesia
PHR
$663M
| $16.5M | 3.42% |
+977,152
| New | +$20.2M |
|
|
FOLD
13
DELISTED
Amicus Therapeutics
FOLD
| $16.4M | 3.38% |
1,150,000
-559,533
| -33% | -$5.5M |
|
|
SEM
14
DELISTED
Select Medical
SEM
| $15.4M | 3.18% |
1,035,086
+160,171
| +18% | +$2.26M |
|
15
Syndax Pharmaceuticals
SNDX
$2.12B
| $14M | 2.89% |
665,000
-338,400
| -34% | -$5.9M |
|
16
Zymeworks
ZYME
$1.81B
| $14M | 2.89% |
530,393
-219,218
| -29% | -$4.78M |
|
|
17
Roivant Sciences
ROIV
$25.2B
| $13.6M | 2.81% |
627,162
-708,338
| -53% | -$14M |
|
18
Crinetics Pharmaceuticals
CRNX
$8.88B
| $12.2M | 2.53% |
262,904
-65,780
| -20% | -$2.93M |
|
19
Avantor
AVTR
$7.63B
| $10.3M | 2.13% |
+898,499
| New | +$11.1M |
|
20
Shattuck Labs
STTK
$609M
| $8.69M | 1.8% |
2,381,502
-3,069,693
| -56% | -$7.32M |
|
21
Labcorp
LH
$22.5B
| $8.66M | 1.79% |
+34,532
| New | +$9.17M |
|
22
GeneDx Holdings
WGS
$1.86B
| $7.15M | 1.48% |
+55,000
| New | +$7.55M |
|
23
Alnylam Pharmaceuticals
ALNY
$37.4B
| $6.8M | 1.41% |
+17,109
| New | +$7.57M |
|
|
24
Immunovant
IMVT
$8.06B
| $6.19M | 1.28% |
243,404
-455,068
| -65% | -$10.1M |
|
25
Corbus Pharmaceuticals
CRBP
$165M
| $5.57M | 1.15% |
683,872
+340,472
| +99% | +$4.2M |
|
Similar funds
PL
BFC
ACM
FFWA
SAM
CBB
AIG
IA